These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

979 related items for PubMed ID: 11606325

  • 1. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.
    Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
    [Abstract] [Full Text] [Related]

  • 2. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V.
    FEBS Lett; 2000 Oct 13; 483(1):52-6. PubMed ID: 11033355
    [Abstract] [Full Text] [Related]

  • 3. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):275-84. PubMed ID: 10448105
    [Abstract] [Full Text] [Related]

  • 4. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.
    De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V.
    J Biol Chem; 2001 Apr 20; 276(16):12856-63. PubMed ID: 11278420
    [Abstract] [Full Text] [Related]

  • 5. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V.
    Biochem Pharmacol; 2003 May 01; 65(9):1473-81. PubMed ID: 12732359
    [Abstract] [Full Text] [Related]

  • 6. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):444-51. PubMed ID: 11181068
    [Abstract] [Full Text] [Related]

  • 7. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.
    Vandevoorde S, Lambert DM, Smart D, Jonsson KO, Fowler CJ.
    Bioorg Med Chem; 2003 Mar 20; 11(6):817-25. PubMed ID: 12614867
    [Abstract] [Full Text] [Related]

  • 8. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ.
    Br J Pharmacol; 2001 Aug 20; 133(8):1263-75. PubMed ID: 11498512
    [Abstract] [Full Text] [Related]

  • 9. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R, De Petrocellis L.
    FEBS Lett; 1998 Oct 09; 436(3):449-54. PubMed ID: 9801167
    [Abstract] [Full Text] [Related]

  • 10. Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats.
    McQueen DS, Bond SM, Smith PJ, Balali-Mood K, Smart D.
    Eur J Pharmacol; 2004 May 03; 491(2-3):181-9. PubMed ID: 15140635
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2001 Feb 03; 132(3):631-40. PubMed ID: 11159715
    [Abstract] [Full Text] [Related]

  • 12. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L.
    Biochem J; 2001 Aug 15; 358(Pt 1):249-55. PubMed ID: 11485574
    [Abstract] [Full Text] [Related]

  • 13. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart JF, Maccarrone M.
    J Med Chem; 2002 Aug 15; 45(17):3709-20. PubMed ID: 12166944
    [Abstract] [Full Text] [Related]

  • 14. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
    Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR.
    J Pharmacol Exp Ther; 2002 Mar 15; 300(3):984-91. PubMed ID: 11861807
    [Abstract] [Full Text] [Related]

  • 15. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
    De Petrocellis L, Davis JB, Di Marzo V.
    FEBS Lett; 2001 Oct 12; 506(3):253-6. PubMed ID: 11602256
    [Abstract] [Full Text] [Related]

  • 16. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
    Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB, Smart D.
    Br J Anaesth; 2002 Dec 12; 89(6):882-7. PubMed ID: 12453933
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bär PR, Nicolay K, Di Marzo V.
    J Neurosci; 2003 May 15; 23(10):4127-33. PubMed ID: 12764100
    [Abstract] [Full Text] [Related]

  • 18. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ.
    Eur J Pharmacol; 2001 May 25; 420(2-3):123-31. PubMed ID: 11408034
    [Abstract] [Full Text] [Related]

  • 19. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.
    Smart D, Jonsson KO, Vandevoorde S, Lambert DM, Fowler CJ.
    Br J Pharmacol; 2002 Jun 25; 136(3):452-8. PubMed ID: 12023948
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R, Ho WS, Bottrill FE, Ford WR, Hiley CR.
    Br J Pharmacol; 2001 Oct 25; 134(4):921-9. PubMed ID: 11606334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.